iBio, Inc. financial data

Symbol
IBIO on NYSE
Industry
Pharmaceutical Preparations
Location
600 Madison Avenue, Suite 1601, New York, NY
State of incorporation
DE
Fiscal year end
June 30
Former names
iBioPharma, Inc. (to 8/14/2009), InB:Biotechnologies, Inc. (to 7/17/2008)
Latest financial report
10-K/A - Q2 2024 - Sep 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 140 % -5.84%
Quick Ratio 0 %
Debt-to-equity 120 % -2.06%
Return On Equity -260 % -332%
Return On Assets -117 % -182%
Operating Margin -53.6K % -2906%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.64M shares -68.7%
Common Stock, Shares, Outstanding 8.62M shares +749%
Entity Public Float 4.43M USD -18.5%
Common Stock, Value, Issued 9K USD +800%
Weighted Average Number of Shares Outstanding, Basic 3.83M shares +526%
Weighted Average Number of Shares Outstanding, Diluted 3.83M shares +526%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 50K USD -97.2%
Revenue from Contract with Customer, Excluding Assessed Tax 50K USD
Research and Development Expense 5.19M USD -49.8%
General and Administrative Expense 11.7M USD -38.6%
Operating Income (Loss) -16.6M USD +43.3%
Nonoperating Income (Expense) 1.19M USD +3622%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -65M USD -29.2%
Earnings Per Share, Basic -6.5 USD/shares +93.9%
Earnings Per Share, Diluted -6.5 USD/shares +93.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.2M USD +230%
Cash, Cash Equivalents, and Short-term Investments 6.43M USD -34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD
Assets, Current 15.7M USD -40.3%
Property, Plant and Equipment, Net 3.63M USD -13.9%
Operating Lease, Right-of-Use Asset 2.4M USD -11.8%
Intangible Assets, Net (Excluding Goodwill) 5.37M USD -0.37%
Assets 28.7M USD -30.3%
Accounts Payable, Current 358K USD -80.6%
Employee-related Liabilities, Current 1.57M USD -59.6%
Accrued Liabilities, Current 2.03M USD -55.5%
Contract with Customer, Liability, Current 200K USD
Liabilities, Current 3.84M USD -82.6%
Operating Lease, Liability, Noncurrent 2.69M USD -14%
Liabilities 7.41M USD -71.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -167K USD -83.5%
Retained Earnings (Accumulated Deficit) -314M USD -8.62%
Stockholders' Equity Attributable to Parent 21.3M USD +38.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 21.3M USD +38.6%
Liabilities and Equity 28.7M USD -30.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.34M USD +61.7%
Net Cash Provided by (Used in) Financing Activities 2.47M USD +117%
Net Cash Provided by (Used in) Investing Activities 50K USD +72.4%
Common Stock, Shares Authorized 275M shares 0%
Common Stock, Shares, Issued 8.62M shares +749%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.82M USD +78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.4M USD +90.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD +6.95%
Deferred Tax Assets, Valuation Allowance 54.9M USD +10.7%
Depreciation 165K USD -39.1%
Payments to Acquire Property, Plant, and Equipment 2.48M USD +121%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD +8.68%
Property, Plant and Equipment, Gross 4.64M USD +0.52%
Operating Lease, Liability, Current 436K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 669K USD +53.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 648K USD +66.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 688K USD +40.4%
Deferred Tax Assets, Operating Loss Carryforwards 49.1M USD +14.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 709K USD +29.9%
Operating Lease, Payments 563K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20K USD -84.1%
Share-based Payment Arrangement, Expense 1.98M USD -31%
Interest Expense 52K USD +48.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%